NCT07223047
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07223047
Title A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Local Institution - 0009 NOT_YET_RECRUITING Baltimore Maryland 21287 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
Local Institution - 0002 NOT_YET_RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution - 0010 NOT_YET_RECRUITING Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0006 NOT_YET_RECRUITING Badalona Barcelona [Barcelona] 08916 Spain Details
Local Institution - 0008 NOT_YET_RECRUITING Hortaleza Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field